Company Description
BioScience Health Innovations (OTC Link: BHIC) is a publicly traded pharmaceutical retailers company in the Healthcare sector. The company has a market capitalization of $49.4M.
BHIC stock has gained 0.0% over the past year. Shares last traded at $4.01.
On a trailing twelve-month basis, BioScience Health Innovations reported revenue of $5.7M with net income of $642K and diluted earnings per share of $0.06. The company operates at a net profit margin of 11.3%.
This page provides a comprehensive overview of BHIC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BioScience Health Innovations (BHIC) stock last traded at $4.01, down 0.25% from the previous close. At a market capitalization of $49.4M, BHIC is classified as a micro-cap stock with approximately 11.4M shares outstanding.
BHIC Rankings
Latest News
BioScience Health Innovations has 1 recent news article. Key topics include partnership. View all BHIC news →
SEC Filings
BioScience Health Innovations has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-K, 1 Form 1-A, 1 Form 10-Q. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHIC SEC filings →
Financial Highlights
BioScience Health Innovations generated $5.7M in revenue over the trailing twelve months, retaining a 57.0% gross margin, operating income reached $719K (12.6% operating margin), and net income was $642K, reflecting a 11.3% net profit margin. Diluted earnings per share stood at $0.06. The company generated $172K in operating cash flow.
Upcoming Events
Short Interest History
Days to Cover History
BHIC Company Profile & Sector Positioning
BioScience Health Innovations (BHIC) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.